Valentina Valentina Chiodi

Dr. Valentina Valentina Chiodi

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AZAnna Rita Zuena
Anna Rita Zuena
JMJerome Mairesse
Jerome Mairesse
PCPaola Casolini
Paola Casolini
CCCarlo Cinque
Carlo Cinque
GAGiovanni Sebastiano Alemà
Giovanni Sebastiano Alemà
SMStefania Maccari
Stefania Maccari
Prenatal Restraint Stress (PRS) in rats is a validated model of early stress resulting in permanent behavioral and neurobiological outcomes. Although sexual dimorphism in the effects of PRS has been hypothesized for more than 30 years, few studies in this long period have directly addressed the issue. Our group has uncovered a pronounced gender difference in the effects of PRS (stress delivered to the mothers 3 times per day during the last 10 days of pregnancy) on anxiety, spatial learning, and a series of neurobiological parameters classically associated with hippocampus-dependent behaviors. Adult male rats subjected to PRS (“PRS rats”) showed increased anxiety-like behavior in the elevated plus maze (EPM), a reduction in the survival of newborn cells in the dentate gyrus, a reduction in the activity of mGlu1/5 metabotropic glutamate receptors in the ventral hippocampus, and an increase in the levels of brain-derived neurotrophic factor (BDNF) and pro-BDNF in the hippocampus. In contrast, female PRS rats displayed reduced anxiety in the EPM, improved learning in the Morris water maze, an increase in the activity of mGlu1/5 receptors in the ventral and dorsal hippocampus, and no changes in hippocampal neurogenesis or BDNF levels. The direction of the changes in neurogenesis, BDNF levels and mGlu receptor function in PRS animals was not consistent with the behavioral changes, suggesting that PRS perturbs the interdependency of these particular parameters and their relation to hippocampus-dependent behavior. Our data suggest that the epigenetic changes in hippocampal neuroplasticity induced by early environmental challenges are critically sex-dependent and that the behavioral outcome may diverge in males and females.

1 September 2019 in Pharmacological Research
Verified
Journal Article
Closed access
MDMaria Rosaria Domenici
Maria Rosaria Domenici
AFAntonella Ferrante
Antonella Ferrante
AMAlberto Martire
Alberto Martire
VCValentina Valentina Chiodi
Valentina Valentina Chiodi
RPRita Pepponi
Rita Pepponi
PPPatrizia Popoli
Patrizia Popoli

2 December 2010 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
AMAlberto Martire
Alberto Martire
MTMaria Teresa Tebano
Maria Teresa Tebano
VCValentina Valentina Chiodi
Valentina Valentina Chiodi
SFSamira Ferreira
Samira Ferreira
Rodrigo CunhaRodrigo Cunha
Rodrigo Cunha
PPPatrizia Popoli
Patrizia Popoli

14 April 2015 in Frontiers in Behavioral Neuroscience
Verified
Journal Article
Open access
PDF file
BFBianca De Filippis
Bianca De Filippis
VCValentina Valentina Chiodi
Valentina Valentina Chiodi
WAWalter Adriani
Walter Adriani
ELEnza Lacivita
Enza Lacivita
CMCinzia Mallozzi
Cinzia Mallozzi
Giovanni LaviolaGiovanni Laviola
Giovanni Laviola
Rett syndrome (RTT) is a rare neurodevelopmental disorder, characterized by severe behavioral and physiological symptoms. Mutations in the methyl CpG binding protein 2 gene (MECP2) cause more than 95% of classic cases, and currently there is no cure for this devastating disorder. Recently we have demonstrated that specific behavioral and brain molecular alterations can be rescued in MeCP2-308 male mice, a RTT mouse model, by pharmacological stimulation of the brain serotonin receptor 7 (5-HT7R). This member of the serotonin receptor family – crucially involved in the regulation of brain structural plasticity and cognitive processes – can be stimulated by systemic repeated treatment with LP-211, a brain-penetrant selective 5-HT7R agonist. The present study extends previous findings by demonstrating that the LP-211 treatment (0.25 mg/kg, once per day for 7 days) rescues RTT-related phenotypic alterations, motor coordination (Dowel test), spatial reference memory (Barnes maze test) and synaptic plasticity (hippocampal long-term-potentiation) in MeCP2-308 heterozygous female mice, the genetic and hormonal milieu that resembles that of RTT patients. LP-211 also restores the activation of the ribosomal protein S6, the downstream target of mTOR and S6 kinase, in the hippocampus of RTT female mice. Notably, the beneficial effects on neurobehavioral and molecular parameters of a seven-day long treatment with LP-211 were evident up to two months after the last injection, thus suggesting long-lasting effects on RTT-related impairments. Taken together with our previous study, these results provide compelling preclinical evidence of the potential therapeutic value for RTT of a pharmacological approach targeting the brain 5-HT7R.

1 June 2015 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
BFBianca De Filippis
Bianca De Filippis
DVDaniela Valenti
Daniela Valenti
VCValentina Valentina Chiodi
Valentina Valentina Chiodi
AFAntonella Ferrante
Antonella Ferrante
Lidia de BariLidia de Bari
Lidia de Bari
Giovanni LaviolaGiovanni Laviola
Giovanni Laviola

3 September 2009 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
MTMaria Teresa Tebano
Maria Teresa Tebano
AMAlberto Martire
Alberto Martire
VCValentina Valentina Chiodi
Valentina Valentina Chiodi
RPRita Pepponi
Rita Pepponi
AFAntonella Ferrante
Antonella Ferrante
PPPatrizia Popoli
Patrizia Popoli
Adenosine A2A, cannabinoid CB1 and metabotropic glutamate 5 (mGlu5) receptors are all highly expressed in the striatum. The aim of the present work was to investigate whether, and by which mechanisms, the above receptors interact in the regulation of striatal synaptic transmission. By extracellular field potentials (FPs) recordings in corticostriatal slices, we demonstrated that the ability of the selective type 1 cannabinoid receptor (CB1R) agonist WIN55,212‐2 to depress synaptic transmission was prevented by the pharmacological blockade or the genetic inactivation of A2ARs. Such a permissive effect of A2ARs towards CB1Rs does not seem to occur pre‐synaptically as the ability of WIN55,212‐2 to increase the R2/R1 ratio under a protocol of paired‐pulse stimulation was not modified by ZM241385. Furthermore, the effects of WIN55,212‐2 were reduced in slices from mice lacking post‐synaptic striatal A2ARs. The selective mGlu5R agonist (RS)‐2‐chloro‐5‐hydroxyphenylglycine (CHPG) potentiated the synaptic effects of WIN55,212‐2, and such a potentiation was abolished by A2AR blockade. Unlike the synaptic effects, the ability of WIN55,212‐2 to prevent NMDA‐induced toxicity was not influenced by ZM241385. Altogether, these results show that the state of activation of A2ARs regulates the synaptic effects of CB1Rs and that A2ARs may control CB1 effects also indirectly, namely through mGlu5Rs.